TP53 and chronic myelogenous leukemia, BCR-ABL1 positive: To test the therapeutic potential of p53 activation by nutlin3a in BC CML, we first examined the expression of p53 using previously stored mononuclear cell lysates isolated from samples obtained from patients with BC CML by western blot.